What’s your next big idea?
We believe there is a major shift in thinking in North America and Europe towards acceptance of what have traditionally been known as “alternative medicines”. As more companies in this space adopt a scientific method to support health benefit claims, the more mainstream it will become. We are witnessing this right now with the gradual acceptance of cannabis as a medicine in countries across the world, increasingly supported by detailed studies documenting its medicinal properties and beneficial effects. Beyond cannabis, the broader nutraceutical industry is undergoing significant annual growth and presents some very exciting investment opportunities.
We are also currently exploring new models for delivery of certain healthcare services at a low enough cost that it can be affordable in the poorest communities across the developing world. We have some very exciting work underway on this theme.
Closer to home in the UK we are looking at innovative technology leveraged solutions in the provision of dementia care services.